Authors:
LITVAN I
JANKOVIC J
GOETZ CG
WENNING GK
SASTRY N
JELLINGER K
MCKEE A
LAI EC
BRANDEL JP
VERNY M
RAYCHAUDHURI K
PEARCE RKB
BARTKO JJ
AGID Y
Citation: I. Litvan et al., ACCURACY OF THE CLINICAL-DIAGNOSIS OF POSTENCEPHALITIC PARKINSONISM -A CLINICOPATHOLOGICAL STUDY, European journal of neurology, 5(5), 1998, pp. 451-457
Citation: Rkb. Pearce et al., DE-NOVO ADMINISTRATION OF ROPINIROLE AND BROMOCRIPTINE INDUCES LESS DYSKINESIA THAN L-DOPA IN THE MPTP-TREATED MARMOSET, Movement disorders, 13(2), 1998, pp. 234-241
Authors:
KANDA T
JACKSON MJ
SMITH LA
PEARCE RKB
NAKAMURA J
KASE H
KUWANA Y
JENNER P
Citation: T. Kanda et al., ADENOSINE A(2A) ANTAGONIST - A NOVEL ANTIPARKINSONIAN AGENT THAT DOESNOT PROVOKE DYSKINESIA IN PARKINSONIAN MONKEYS, Annals of neurology, 43(4), 1998, pp. 507-513
Authors:
LITVAN I
BOOTH V
WENNING GK
BARTKO JJ
GOETZ CG
MCKEE A
JANKOVIC J
JELLINGER K
LAI EC
BRANDEL JP
VERNY M
CHAUDHURI KR
PEARCE RKB
AGID Y
Citation: I. Litvan et al., RETROSPECTIVE APPLICATION OF A SET OF CLINICAL DIAGNOSTIC-CRITERIA FOR THE DIAGNOSIS OF MULTIPLE SYSTEM ATROPHY, Journal of neural transmission, 105(2-3), 1998, pp. 217-227
Authors:
TEL BC
ZENG BY
PEARCE RKB
ROSE S
JENNER P
MARSDEN CD
Citation: Bc. Tel et al., CHANGES IN STRIATAL PREPROENKEPHALIN A (PPE-A) AND PREPROTACHYKININ (PPT) MESSENGER-RNA EXPRESSION - THE EFFECTS OF L-DOPA, BROMOCRIPTINE, AND ROPINIROLE IN MPTP-TREATED MARMOSETS, Neurology, 50(4), 1998, pp. 3013-3013
Authors:
MARATOS E
SMITH L
JACKSON MJ
PEARCE RKB
JENNER P
MARSDEN CD
Citation: E. Maratos et al., INDUCING DYSKINESIA IN MPTP-TREATED COMMON MARMOSETS - THE EFFECTS OFREPEATED TREATMENT WITH COMBINATIONS OF L-DOPA AND ROPINIROLE, Neurology, 50(4), 1998, pp. 3014-3014
Authors:
WENNING GK
LITVAN I
JANKOVIC J
GRANATA R
MANGONE CA
MCKEE A
POEWE W
JELLINGER K
CHAUDHURI KR
DOLHABERRIAGUE L
PEARCE RKB
Citation: Gk. Wenning et al., NATURAL-HISTORY AND SURVIVAL OF 14 PATIENTS WITH CORTICOBASAL DEGENERATION CONFIRMED AT POSTMORTEM EXAMINATION, Journal of Neurology, Neurosurgery and Psychiatry, 64(2), 1998, pp. 184-189
Authors:
MARATOS E
SMITH L
JACKSON MJ
PEARCE RKB
JENNER P
MARSDEN CD
Citation: E. Maratos et al., EFFECTS OF REPEATED TREATMENT WITH COMBINATIONS OF L-DOPA AND ROPINIROLE ON DYSKINESIA INDUCTION IN MPTP-TREATED COMMON MARMOSETS, British Journal of Pharmacology, 123, 1998, pp. 252-252
Authors:
LITVAN I
MACINTYRE A
GOETZ CG
WENNING GK
JELLINGER K
VERNY M
BARTKO JJ
JANKOVIC J
MCKEE A
BRANDEL JP
CHAUDHURI KR
LAI EC
DOLHABERRIAGUE L
PEARCE RKB
AGID Y
Citation: I. Litvan et al., ACCURACY OF THE CLINICAL DIAGNOSES OF LEWY BODY DISEASE, PARKINSON-DISEASE, AND DEMENTIA WITH LEWY BODIES, Archives of neurology, 55(7), 1998, pp. 969-978
Authors:
PEARCE RKB
OWEN A
DANIEL S
JENNER P
MARSDEN CD
Citation: Rkb. Pearce et al., ALTERATIONS IN THE DISTRIBUTION OF GLUTATHIONE IN THE SUBSTANTIA-NIGRA IN PARKINSONS-DISEASE, Journal of neural transmission, 104(6-7), 1997, pp. 661-677
Authors:
LITVAN I
AGID Y
SASTRJ N
JANKOVIC J
WENNING GK
GOETZ CG
VERNY M
BRANDEL JP
JELLINGER K
CHAUDHURI KR
MCKEE A
LAI EC
PEARCE RKB
BARTKO JJ
Citation: I. Litvan et al., WHAT ARE THE OBSTACLES FOR AN ACCURATE CLINICAL-DIAGNOSIS OF PICKS-DISEASE - A CLINICOPATHOLOGICAL STUDY, Neurology, 49(1), 1997, pp. 62-69
Authors:
JENNER P
PEARCE RKB
BANERJI T
DESAI NB
JACKSON MJ
MARSDEN CD
Citation: P. Jenner et al., A COMPARISON OF ROPINIROLE, L-DOPA, AND BROMOCRIPTINE TREATMENT ON THE DEVELOPMENT OF DYSKINESIA IN MPTP-TREATED COMMON MARMOSETS, Neurology, 48(3), 1997, pp. 2085-2085
Authors:
LITVAN I
AGID Y
GOETZ C
JANKOVIC J
WENNING GK
BRANDEL JP
LAI EC
VERNY M
RAYCHAUDHURI K
MCKEE A
JELLINGER K
PEARCE RKB
BARTKO JJ
Citation: I. Litvan et al., ACCURACY OF THE CLINICAL-DIAGNOSIS OF CORTICOBASAL DEGENERATION - A CLINICOPATHOLOGICAL STUDY, Neurology, 48(1), 1997, pp. 119-125
Authors:
ZENG BY
TEL BC
PEARCE RKB
SMITH LA
CHANCHARME L
MOACHON G
ROSE S
JENNER P
MARSDEN CD
Citation: By. Zeng et al., NEUROPROTECTIVE EFFECT OF MODAFINIL AGAINST MPTP TOXICITY IN MPTP-TREATED COMMON MARMOSETS, British Journal of Pharmacology, 122, 1997, pp. 44-44
Authors:
TEL BC
ZENG BY
PEARCE RKB
ROSE S
JENNER P
MARSDEN CD
Citation: Bc. Tel et al., DIFFERENTIAL-EFFECTS OF ROPINIROLE, BROMOCRIPTINE AND L-DOPA ON STRIATAL PREPROENKEPHALIN AND PREPROTACHYKININ MESSENGER-RNA EXPRESSION IN MPTP-TREATED COMMON MARMOSETS, British Journal of Pharmacology, 122, 1997, pp. 161-161
Citation: S. Costa et al., INTRAVENTRICULAR ADMINISTRATION OF GLIAL-CELL-LINE-DERIVED NEUROTROPHIC FACTOR IN THE MPTP-TREATED COMMON MARMOSET, British Journal of Pharmacology, 122, 1997, pp. 162-162
Authors:
TEL BC
ZENG BY
PEARCE RKB
ROSE S
JENNER P
MARSDEN CD
Citation: Bc. Tel et al., DIFFERENTIAL-EFFECTS OF ROPINIROLE, BROMOCRIPTINE AND L-DOPA ON STRIATAL DOPAMINE D-2 RECEPTOR-BINDING IN MPTP-TREATED COMMON MARMOSETS, British Journal of Pharmacology, 122, 1997, pp. 315-315
Authors:
LITVAN I
CAMPBELL G
MANGONE CA
VERNY M
MCKEE A
CHAUDHURI KR
JELLINGER K
PEARCE RKB
DOLHABERRIAGUE L
Citation: I. Litvan et al., WHICH CLINICAL-FEATURES DIFFERENTIATE PROGRESSIVE SUPRANUCLEAR PALSY (STEELE-RICHARDSON-OLSZEWSKI SYNDROME) FROM RELATED DISORDERS - A CLINICOPATHOLOGICAL STUDY, Brain, 120, 1997, pp. 65-74
Authors:
LITVAN I
GOETZ CG
JANKOVIC J
WENNING GK
BOOTH V
BARTKO JJ
MCKEE A
JELLINGER K
LAI EC
BRANDEL JP
VERNY M
CHAUDHURI KR
PEARCE RKB
AGID Y
Citation: I. Litvan et al., WHAT IS THE ACCURACY OF THE CLINICAL-DIAGNOSIS OF MULTIPLE SYSTEM ATROPHY - A CLINICOPATHOLOGICAL STUDY, Archives of neurology, 54(8), 1997, pp. 937-944
Authors:
LITVAN I
AGID Y
JANKOVIC J
GOETZ C
BRANDEL JP
LAI EC
WENNING G
DOLHABERRIAGUE L
VERNY M
CHAUDHURI KR
MCKEE A
JELLINGER K
BARTKO JJ
MANGONE CA
PEARCE RKB
Citation: I. Litvan et al., ACCURACY OF CLINICAL-CRITERIA FOR THE DIAGNOSIS OF PROGRESSIVE SUPRANUCLEAR PALSY (STEELE-RICHARDSON-OLSZEWSKI SYNDROME), Neurology, 46(4), 1996, pp. 922-930
Authors:
BANERJI T
PEARCE RKB
TRESEDAR S
JACKSON MJ
JENNER P
MARSDEN CD
Citation: T. Banerji et al., EFFECTS OF CENTRAL AND PERIPHERAL CHOLINERGIC DRUGS ON LOCOMOTOR-ACTIVITY AND L-DOPA-INDUCED DYSKINESIA IN MPTP-TREATED COMMON MARMOSETS (CALLITHRIX-JACCHUS), British Journal of Pharmacology, 119, 1996, pp. 29-29